Why Fed Rate Hike Was ‘Baked Into the Cake’
As widely expected in the U.S. capital markets today, the Federal Reserve didn’t veer off its rate-hiking path by implementing another increase…
CNBC
Survey Says China Won’t Mimic Fed’s Rate-Hiking Measures
In terms of gross domestic product, China may trail the United States, but it won’t play a game of follow the leader…
Hawkish Fed Expected to Raise Interest Rates Today
The common notion in the capital markets today is to expect the expected as the Federal Reserve will likely maintain their hawkish…
Continued Rate Hikes a Boon for ‘TMV’ ETF
While the U.S. economy continues its forward momentum with tailwinds from a strong stock market that has already seen major indexes like…
Survey Unanimous Fed will Raise Rates Twice More this Year
The U.S. economy continues to move forward at a significant speed with tailwinds from a strong stock market that has already seen…
Treasury Yields Show Recovery Could End Soon
The fixed-income market points to the 2- and 10-year Treasury yields flattening and inverting as a precursor to a recession. It’s certainly…
No Signs of Recession, Says Chief Investment Officer
Tom Manning, F.L. Putnam Investment Management Company president and CEO, and Krishna Memani, OppenheimerFunds chief investment officer and head of fixed income,…
Mnuchin: Progress on China Trade Talks
Treasury Secretary Steven Mnuchin provides insight to his comment that a trade war with China is “on hold” in a CNBC segment. …
Video: Look Overseas for Opportunity in ETFs
At this week’s Schwab Impact Conference in Boston ETF Trends editor-in-chief Tom Lydon sat down with Jeff Cox of MSNBC to give…
Tom Lydon Talks Biotech ETFs on CNBC’s Power Lunch
Tom Lydon talked about biotechnology exchange traded funds (ETFs) on CNBC this afternoon. Video of Tom’s segment is below: